- Home
- NTIP vs CCEL Comparison
NTIP vs CCEL Comparison
Compare NTIP & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIP
- CCEL
- Stock Information
- Founded
- NTIP 1990
- CCEL 1989
- Country
- NTIP United States
- CCEL United States
- Employees
- NTIP N/A
- CCEL N/A
- Industry
- NTIP Multi-Sector Companies
- CCEL Managed Health Care
- Sector
- NTIP Miscellaneous
- CCEL Health Care
- Exchange
- NTIP Nasdaq
- CCEL Nasdaq
- Market Cap
- NTIP 32.0M
- CCEL 34.8M
- IPO Year
- NTIP 1998
- CCEL 1997
- Fundamental
- Price
- NTIP $1.60
- CCEL $4.40
- Analyst Decision
- NTIP
- CCEL Strong Buy
- Analyst Count
- NTIP 0
- CCEL 1
- Target Price
- NTIP N/A
- CCEL $8.50
- AVG Volume (30 Days)
- NTIP 65.6K
- CCEL 25.6K
- Earning Date
- NTIP 10-23-2025
- CCEL 10-14-2025
- Dividend Yield
- NTIP 6.25%
- CCEL 13.41%
- EPS Growth
- NTIP N/A
- CCEL N/A
- EPS
- NTIP N/A
- CCEL N/A
- Revenue
- NTIP $150,000.00
- CCEL $31,988,783.00
- Revenue This Year
- NTIP N/A
- CCEL $1.75
- Revenue Next Year
- NTIP N/A
- CCEL N/A
- P/E Ratio
- NTIP N/A
- CCEL N/A
- Revenue Growth
- NTIP N/A
- CCEL 1.10
- 52 Week Low
- NTIP $1.16
- CCEL $4.09
- 52 Week High
- NTIP $1.90
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- NTIP 55.71
- CCEL 44.99
- Support Level
- NTIP $1.56
- CCEL $4.26
- Resistance Level
- NTIP $1.63
- CCEL $4.70
- Average True Range (ATR)
- NTIP 0.08
- CCEL 0.19
- MACD
- NTIP -0.01
- CCEL -0.00
- Stochastic Oscillator
- NTIP 28.57
- CCEL 34.93
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.